Our Therapies
Innovative Care,
Guided by Science
BrioMD's offers next-generation, patented cell-infusion therapies engineered to target neurological inflammation and elevate brain function.
Built on strict clinical processes and delivered in controlled environments, the therapy adheres to FDA-aligned regulations and precise procedural standards.
As a non-invasive adjunct to traditional treatments, Neuro-Free is designed to drive consistent functional improvements through well-structured protocols.
All Neuro-Free treatments are administered in the United States by certified medical doctors and registered nurses with advanced training.
Real Results
Real Science
Built on proven cellular research and precise, physician-guided methodology.
Diverse needs, directed care.
BrioMD Labs delivers comprehensive, clinician-guided care designed to address a wide spectrum of needs across different stages and circumstances of life. Our cell-therapy approach is built to support individuals experiencing symptoms associated with autism, traumatic brain injury, epilepsy, and inflammation-related heart conditions, offering a non-invasive pathway grounded in scientific rigor and careful oversight. With a focus on safety, precision, and individualized treatment planning, BrioMD Labs provides access to innovative care that meets people where they are and helps them move toward healthier, more stable outcomes.
Our Therapies
Neuro-Free®
Created after one family watched countless children run out of options and hope, Neuro-Free is a science-backed cell-infusion therapy that helps exceptional children unlock a fuller, freer life, one small win at a time. Our patented cell infusion therapy applies advanced medical science through a carefully designed process focused on safety, clinical oversight, and reliable treatment protocols. The goal: to empower children whose neurological challenges limit everyday experiences.
Signolii®
Signolii® is an infusion therapy developed by BrioMD Labs to support neurological wellness in people living with the long-term effects of traumatic brain injury (TBI) or epilepsy. Backed by rigorous protocols and delivered under careful medical oversight, Signolii is designed to complement—not replace—traditional care, offering progress that can feel personal: fewer seizures, clearer focus, and steadier days.
Kaorta®
Kaorta is a targeted cell-therapy treatment from BrioMD Labs designed to address neuropathy and congestive heart failure by reducing inflammation and restoring healthier nerve and cardiovascular function. Built on proven cellular science and supported by FDA-aligned protocols, Kaorta delivers a more advanced approach for patients who require specialized harvesting and clinician-guided care. With meaningful improvements reported across cardiac and neurological symptoms, Kaorta offers a promising option when traditional treatments provide limited relief.
